4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioAtla, Inc. (BCAB) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 41 employees. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-12-31, BCAB reported $2M in revenue and ($60M) in net income.
BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
Interactive charts & full statements → Open the BCAB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $11M | $0M | $0M | — |
| Operating Income (EBIT) | ($59M) | ($74M) | ($130M) | ($108M) | — |
| Net Income | ($60M) | ($70M) | ($124M) | ($106M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $2M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($9M) | ($14M) | ($19M) | ($18M) | — |
| Net Income | ($6M) | ($10M) | ($16M) | ($19M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $14M | $52M | $120M | $226M | — |
| Total Liabilities | $50M | $38M | $49M | $45M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BCAB viewer.
About TickerBase · Data methodology & sources